Article

Scientists try to find easier way to detect early diabetic retinopathy

Beams of light are being used as a less invasive, less expensive approach to spot early stages of retinal damage from diabetic retinopathy by measuring blood flow in the back of the eye, according to scientists in California.

Washington, DC-Beams of light are being used as a less invasive, less expensive approach to spot early stages of retinal damage from diabetic retinopathy by measuring blood flow in the back of the eye, according to scientists in California.

"The more severe the retinopathy, the lower the blood flow to the retina," said David Huang, MD, of the Keck School of Medicine, University of Southern California, Los Angeles.

According to the U.S. Centers for Disease Control and Prevention, 5.5 million people over the age of 40 suffered from this condition in 2005, and this number is expected to triple by 2050 as the number of people with diabetes continues to increase. Vision loss is preventable if retinal damage is detected early.

The scientists adapted optical coherence tomography (OCT)-normally used to take cross-sectional pictures of the retina-to detect directly the amount of blood flowing through retinal blood vessels.

Dr. Huang's research takes advantage of Interactive Science Publishing (ISP), an initiative undertaken by the Optical Society of America in partnership with the National Library of Medicine, part of the National Institutes of Health, and with the support of the U.S. Air Force Office of Scientific Research. For more information on ISP, visit www. opticsinfobase.org/isp.cfm.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.